Hyrimoz and Potassium iodide drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Hyrimoz (adalimumab-adaz) and Potassium iodide (potassium iodide). Common drug interactions include femoral neck fracture among females and musculoskeletal discomfort among males.

The phase IV clinical study analyzes what interactions people have when they take Hyrimoz and Potassium iodide. It is created by eHealthMe based on reports of 17 people who take the same drugs from the FDA, and is updated regularly.

What is Hyrimoz?

Hyrimoz has active ingredients of adalimumab-adaz. eHealthMe is studying from 4,635 Hyrimoz users. Check the latest studies of Hyrimoz.

What is Potassium iodide?

Potassium iodide has active ingredients of potassium iodide. It is often used in thyroid diseases. eHealthMe is studying from 1,919 Potassium iodide users. Check the latest studies of Potassium iodide.



On Jul, 31, 2026

17 people who take Hyrimoz and Potassium iodide together, and have interactions are studied.

Hyrimoz and Potassium iodide drug interactions.

What are the common drug interactions of Hyrimoz and Potassium Iodide, by gender? *:

female:

  1. Femoral neck fracture (neck of femur bone fracture)
  2. Haematocrit decreased
  3. Haemoglobin decreased
  4. Lymphocyte count decreased
  5. Red blood cell count decreased
  6. Diarrhoea
  7. Intestinal haemorrhage (bleeding from intestine)
  8. Duodenitis (inflammation of the duodenum)
  9. Arthralgia (joint pain)
  10. Blood glucose increased

male:

  1. Musculoskeletal discomfort (discomfort in the body's muscles, joints, tendons, ligaments and nerves)
  2. Arthralgia (joint pain)
  3. Haemorrhoids (a swollen vein or group of veins in the region of the anus)
  4. Influenza like illness
  5. Pityriasis (a skin disease characterized by the shedding of fine flaky scales)

What are the existing conditions these people have? *

  1. Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 9 people, 52.94%
  2. Psoriasis (immune-mediated disease that affects the skin): 8 people, 47.06%
  3. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 4 people, 23.53%

* Approximation only. Some reports may have incomplete information.

Do you take Hyrimoz and Potassium iodide?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Hyrimoz and Potassium iodide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Hyrimoz:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Potassium iodide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Hyrimoz and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Potassium iodide and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on adalimumab-adaz and potassium iodide (the active ingredients of Hyrimoz and Potassium iodide, respectively), and Hyrimoz and Potassium iodide (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: